Taconic Biosciences® Launches Cage+™, Redefining Colony Management Solutions for the Modern Laboratory
February 21, 2022 09:00 ET
|
Taconic Biosciences
RENSSELAER, N.Y., Feb. 21, 2022 (GLOBE NEWSWIRE) -- Taconic Biosciences, a global leader in providing drug discovery animal model solutions, launched Cage+, a holistic, innovative approach to murine...
Taconic Biosciences Launches TruIMPORT™ Importation Solution
May 27, 2021 09:00 ET
|
Taconic Biosciences
RENSSELAER, N.Y., May 27, 2021 (GLOBE NEWSWIRE) -- Taconic Biosciences, a global leader in providing drug discovery animal model solutions, announces a significant enhancement to the Taconic-Cyagen...
Taconic Biosciences Expands Innovative ExpressMODEL® Portfolio
December 03, 2020 09:00 ET
|
Taconic Biosciences
RENSSELAER, New York, Dec. 03, 2020 (GLOBE NEWSWIRE) -- Taconic Biosciences, a global leader in providing drug discovery animal model solutions, announces the launch of the new ExpressMODEL®: Random...
Nancy J. Sandy Appointed Chief Executive Officer of Taconic Biosciences
January 31, 2019 10:01 ET
|
Taconic Biosciences
RENSSELAER, N.Y., Jan. 31, 2019 (GLOBE NEWSWIRE) -- Taconic Biosciences’ Board of Directors has selected Nancy J. Sandy to succeed Dr. Robert J. Rosenthal as Chief Executive Officer (CEO). Effective...
Taconic Biosciences and Cyagen Biosciences Announce Strategic Partnership
July 18, 2018 08:00 ET
|
Taconic Biosciences
RENSSELAER, N.Y., July 18, 2018 (GLOBE NEWSWIRE) -- Taconic Biosciences and Cyagen Biosciences, global leaders in the generation of custom genetically engineered rodent models and associated...